Author

Kendall E. Barrett

University of Wisconsin–MadisonORCID 0000-0002-1543-9986Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:imaging· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

Aaron Matthew LeBeauiD· 2 shared Bryan P. BednarziD· 2 shared Eduardo Aluicio‐SarduyiD· 2 shared Jason C. MixdorfiD· 2 shared Jonathan W. EngleiD· 2 shared Joseph P. GallantiD· 2 shared Kendahl L. OttiD· 2 shared Ohyun KwoniD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aaron Matthew LeBeauORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 13, 2026

Tuning the Structural Properties of a Single-Domain Antibody Scaffold for Improved Fibroblast Activation Protein Targeting

Kendahl L. Ott, Joseph P. Gallant, Ohyun Kwon…·Aaron Matthew LeBeau

This study engineers single-domain antibodies to improve targeting of FAP, showing that valency and molecular weight affect tumor uptake and biodistribution.

DOI 10.64898/2026.03.11.711127

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 11, 2026

A MET-Targeted Variable New Antigen Receptor Theranostic for Non-Small Cell Lung Cancer

Rachel L. Minne, Jayden L. West, Natalie Y. Luo…·Aaron Matthew LeBeau

This paper develops a shark-derived VNAR-based theranostic agent for MET-altered NSCLC, showing imaging and therapeutic efficacy in preclinical models.

DOI 10.64898/2026.01.30.702875

humanmouse

𝕏 PostBluesky